@momolam.bsky.social
Reposted
The only thing I really, really, really want for Christmas is to raise as much money as I can for the Humane Society of Chittenden County. If you want you can help me make that happen! gofund.me/a44dd513
Donate to Help Make Winter Cozy for Potato Bears., organized by Molly Hodgdon
Hello!
If you are here you probably know that my name is Molly and I run… Molly Hodgdon needs your support for Help Make Winter Cozy for Potato Bears.
gofund.me
December 18, 2024 at 2:34 AM
The only thing I really, really, really want for Christmas is to raise as much money as I can for the Humane Society of Chittenden County. If you want you can help me make that happen! gofund.me/a44dd513
Reposted
After Fox co-workers told media he was often drinking or hungover while at work, Pete Hegseth challenged people to find a single clip showing him drinking on the job.
We accepted the challenge.
We accepted the challenge.
“Bottoms Up”— Pete Hegseth Took Swigs from Champagne Bottle, Plunged Into the Alcoholic Beverage During Fox News Broadcast
Hegseth’s kids were present and sampled the dunk tank champagne
meidasnews.com
December 18, 2024 at 11:40 AM
After Fox co-workers told media he was often drinking or hungover while at work, Pete Hegseth challenged people to find a single clip showing him drinking on the job.
We accepted the challenge.
We accepted the challenge.
Reposted
Goldman Sachs analysts : The money men saying the quiet part out loud
Curing patients may not be a sufficiently profitable enterprise for biotech companies.
Chronic disease is a far more beneficial business model
www.cnbc.com/2018/04/11/g...
Curing patients may not be a sufficiently profitable enterprise for biotech companies.
Chronic disease is a far more beneficial business model
www.cnbc.com/2018/04/11/g...
Goldman Sachs asks in biotech research report: 'Is curing patients a sustainable business model?'
Goldman Sachs warns sales from the most successful disease treatments are difficult to maintain.
www.cnbc.com
December 18, 2024 at 10:48 AM
Goldman Sachs analysts : The money men saying the quiet part out loud
Curing patients may not be a sufficiently profitable enterprise for biotech companies.
Chronic disease is a far more beneficial business model
www.cnbc.com/2018/04/11/g...
Curing patients may not be a sufficiently profitable enterprise for biotech companies.
Chronic disease is a far more beneficial business model
www.cnbc.com/2018/04/11/g...